Mayo Clinic Laboratories and Lucence have announced a strategic collaboration to expand access to advanced cancer testing services globally. The partnership aims to leverage the strengths of both organizations to improve patient outcomes worldwide.
Lucence, known for its molecular diagnostics expertise, will provide access to its LiquidHALLMARK technology through Mayo Clinic Laboratories. This technology is a next-generation sequencing liquid biopsy that analyzes circulating tumor DNA (ctDNA) and RNA (ctRNA) for biomarkers across various cancers.
William Morice, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, stated: “We look forward to making LiquidHALLMARK available so physicians and their patients have access to important insights that can inform treatment decisions.” He emphasized that incorporating this test supports their goal of offering comprehensive testing options for complex cases.
The Medicare-covered LiquidHALLMARK test offers actionable findings by providing targeted therapies based on genomic results. It includes detailed descriptions of each finding and associated clinical trials, with graphical maps for understanding cancer genomic profiles and tracking tumor changes over time.
Min-Han Tan, M.B.B.S., F.R.C.P., Ph.D., founding CEO and medical director of Lucence, said: "Working with Mayo Clinic Laboratories will advance our shared goal of making innovative cancer tests available to benefit everyone globally." He highlighted the benefits of combining Lucence's liquid biopsy testing with Mayo Clinic Laboratories' reach and expertise in improving personalized cancer care.
This collaboration marks a significant advancement in oncology diagnostics. By integrating their respective strengths, the two organizations aim to equip healthcare providers with tools for informed decision-making and personalized treatment plans.
Mayo Clinic Laboratories is a wholly-owned subsidiary of Mayo Clinic, which has an indirect financial interest in the technology referenced. Any revenue received will support Mayo Clinic's not-for-profit mission in patient care, education, and research.
